Instil Bio (TIL) Current Assets (2020 - 2026)
Instil Bio (TIL) posted quarterly Current Assets of $188.3 million for Q1 2026, down 14.12% year-over-year from $219.3 million in Q1 2025, and down 1.63% quarter-over-quarter from $191.4 million in Q4 2025.
Instil Bio (TIL) Current Assets (2020 - 2026) Analysis & Trends
Instil Bio's Current Assets history runs 7 years deep, the most recent figure standing at $188.3 million for Q1 2026.
- In Q1 2026, Current Assets fell 14.12% year-over-year to $188.3 million; the TTM figure through Mar 2026 stood at $188.3 million (down 14.12% YoY), while the FY2025 annual figure was $191.4 million, up 53.8% from the prior year.
- Current Assets for Q1 2026 stood at $188.3 million, down from $191.4 million in the prior quarter.
- The five-year high for Current Assets was $390.7 million in Q1 2022, with the low at $124.5 million in Q4 2024.
- The 5-year median for Current Assets is $196.3 million (2025), against an average of $219.7 million.
- The sharpest annual moves came in 2022 and 2025: Current Assets tumbled 41.95% in 2022, then soared 53.8% in 2025.
- Instil Bio's Current Assets stood at $269.4 million in 2022, then slumped by 40.32% to $160.8 million in 2023, then declined by 22.57% to $124.5 million in 2024, then jumped by 53.8% to $191.4 million in 2025, then slipped by 1.63% to $188.3 million in 2026.
- Business Quant data shows TIL's Current Assets at $188.3 million in Q1 2026, $191.4 million in Q4 2025, and $196.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.62 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.63 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.76 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 18.80 Bn |
| 10 | Instil Bio | 50.29 Mn | 50.29 Mn | - | 71.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 71.61 Mn |
| Mar 31, 2026 | 188.30 Mn |
| Dec 31, 2025 | 191.43 Mn |
| Sep 30, 2025 | 196.26 Mn |
| Jun 30, 2025 | 207.39 Mn |
| Mar 31, 2025 | 219.26 Mn |
| Dec 31, 2024 | 124.47 Mn |
| Sep 30, 2024 | 132.57 Mn |
| Jun 30, 2024 | 154.93 Mn |
| Mar 31, 2024 | 161.03 Mn |
| Dec 31, 2023 | 160.76 Mn |
| Sep 30, 2023 | 195.63 Mn |
| Jun 30, 2023 | 220.59 Mn |
| Mar 31, 2023 | 240.12 Mn |
| Dec 31, 2022 | 269.38 Mn |
| Sep 30, 2022 | 313.66 Mn |
| Jun 30, 2022 | 367.68 Mn |
| Mar 31, 2022 | 390.70 Mn |
| Dec 31, 2021 | 464.02 Mn |
| Sep 30, 2021 | 523.09 Mn |